Pediatric Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments; Amendment of Notice, 49657 [2020-17775]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 158 / Friday, August 14, 2020 / Notices
Center for Devices and Radiological
Health guidance documents is available
at https://www.fda.gov/medical-devices/
device-advice-comprehensiveregulatory-assistance/guidancedocuments-medical-devices-andradiation-emitting-products. These
guidance documents are also available
at https://www.regulations.gov. Persons
unable to download an electronic copy
of either ‘‘Cutaneous Electrode for
Recording Purposes—Performance
Criteria for Safety and Performance
Based Pathway; Guidance for Industry
and Food and Drug Administration Staff
(document number 19014)’’ or
‘‘Conventional Foley Catheters—
Performance Criteria for Safety and
Performance Based Pathway; Guidance
for Industry and Food and Drug
Administration Staff (document number
19010)’’ may send an email request to
CDRH-Guidance@fda.hhs.gov to receive
an electronic copy of the document.
Please use the document number and
complete title to identify the guidance
you are requesting.
III. Paperwork Reduction Act of 1995
These guidances contains no
collections of information. Therefore,
Topic
807, subpart E .........................................................................................................................................
‘‘Requests for Feedback on Medical Device Submissions: The Pre-Submission Program and Meetings with Food and Drug Administration Staff’’.
Premarket notification ....
Q-submissions ...............
In the
Federal Register of July 23, 2020, 85 FR
44541, FDA announced that a meeting
of the Pediatric Advisory Committee
would be held on September 15, 2020.
On page 44542, in the third column, the
Procedure portion of the document is
changed to read as follows:
Oral presentations from the public
will be scheduled between
approximately 11:30 a.m. to 12:30 p.m.
Eastern Time.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14,
relating to the advisory committees.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2020–17771 Filed 8–13–20; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2020–N–1648]
Pediatric Advisory Committee; Notice
of Meeting; Establishment of a Public
Docket; Request for Comments;
Amendment of Notice
Food and Drug Administration,
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Food and Drug
Administration (FDA) is announcing an
amendment to the notice of meeting of
the Pediatric Advisory Committee. This
meeting was announced in the Federal
Register of July 23, 2020. The
amendment is being made to reflect a
change in the Procedure portion of the
document. There are no other changes.
FOR FURTHER INFORMATION CONTACT:
Marieann Brill, Office of the
Commissioner, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 32, Rm. 5154, Silver Spring,
MD 20993, 240–402–3838, or FDA
Advisory Committee Information Line,
1–800–741–8138 (301–443–0572 in the
Washington, DC area). Please call the
Information Line for up-to-date
information on this meeting.
Dated: August 10, 2020.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2020–17775 Filed 8–13–20; 8:45 am]
BILLING CODE 4164–01–P
SUMMARY:
khammond on DSKJM1Z7X2PROD with NOTICES
clearance by the Office of Management
and Budget (OMB) under the Paperwork
Reduction Act of 1995 (PRA) (44 U.S.C.
3501–3521) is not required.
However, these guidances refer to
previously approved collections of
information. These collections of
information are subject to review by
OMB under the PRA. The collections of
information in the following FDA
regulations and guidance have been
approved by OMB as listed in the
following table:
21 CFR part; guidance
Dated: August 7, 2020.
Lauren K. Roth,
Associate Commissioner for Policy.
VerDate Sep<11>2014
17:29 Aug 13, 2020
Jkt 250001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2020–N–1677]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Recordkeeping
and Reporting Requirements for
Human Food and Cosmetics
Manufactured From, Processed With,
or Otherwise Containing Material From
Cattle
Food and Drug Administration,
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
49657
OMB control
No.
0910–0120
0910–0756
The Food and Drug
Administration (FDA, Agency, or we) is
announcing an opportunity for public
comment on the proposed collection of
certain information by the Agency.
Under the Paperwork Reduction Act of
1995 (PRA), Federal Agencies are
required to publish notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information, and
to allow 60 days for public comment in
response to the notice. This notice
solicits comments on the information
collection provisions of existing FDA
regulations concerning FDA-regulated
human food, including dietary
supplements, and cosmetics
manufactured from, processed with, or
otherwise containing material derived
from cattle.
SUMMARY:
Submit either electronic or
written comments on the collection of
information by October 13, 2020.
DATES:
You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. Electronic comments must
be submitted on or before October 13,
2020. The https://www.regulations.gov
electronic filing system will accept
comments until 11:59 p.m. Eastern Time
at the end of October 13, 2020.
Comments received by mail/hand
delivery/courier (for written/paper
submissions) will be considered timely
if they are postmarked or the delivery
service acceptance receipt is on or
before that date.
ADDRESSES:
E:\FR\FM\14AUN1.SGM
14AUN1
]]>Agencies
[Federal Register Volume 85, Number 158 (Friday, August 14, 2020)]
[Notices]
[Page 49657]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-17775]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2020-N-1648]
Pediatric Advisory Committee; Notice of Meeting; Establishment of
a Public Docket; Request for Comments; Amendment of Notice
AGENCY: Food and Drug Administration, Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing an
amendment to the notice of meeting of the Pediatric Advisory Committee.
This meeting was announced in the Federal Register of July 23, 2020.
The amendment is being made to reflect a change in the Procedure
portion of the document. There are no other changes.
FOR FURTHER INFORMATION CONTACT: Marieann Brill, Office of the
Commissioner, Food and Drug Administration, 10903 New Hampshire Ave.,
Bldg. 32, Rm. 5154, Silver Spring, MD 20993, 240-402-3838, or FDA
Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in
the Washington, DC area). Please call the Information Line for up-to-
date information on this meeting.
SUPPLEMENTARY INFORMATION: In the Federal Register of July 23, 2020, 85
FR 44541, FDA announced that a meeting of the Pediatric Advisory
Committee would be held on September 15, 2020. On page 44542, in the
third column, the Procedure portion of the document is changed to read
as follows:
Oral presentations from the public will be scheduled between
approximately 11:30 a.m. to 12:30 p.m. Eastern Time.
This notice is issued under the Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.
Dated: August 10, 2020.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2020-17775 Filed 8-13-20; 8:45 am]
BILLING CODE 4164-01-P
